UNC Health

     Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies

• Minimum Personal Protective Equipment Requirements for Hazardous Drug Activities Performed Outside of the Pharmacy
• Minimum Personal Protective Equipment Requirements for Hazardous Drug Activities Performed Inside of the Pharmacy

     System Formulary Restriction:

     Quizartinib tablet orders must be signed by a REMS-certified Hematology/Oncology Attending Physician

     Inpatient use of quizartinib tablets is restricted to patients who meet one of the following criteria:

• Initiation/new-start treatment for adult patients with newly diagnosed FLT3-ITD AML
• Continuation of home therapy

• Lexicomp
• Micromedex
• UpToDate
• FDA Daily Med